Screener
Anika Therapeutics ANIK Business Segments — Gross Profit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Anika Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001171843-26-005012
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $32,610 | $28,219 | $62,222 | $54,387 |
| Cost of product revenue | 11,366 | 13,856 | 21,981 | 25,343 |
| Gross Profit | 21,244 | 14,363 | 40,241 | 29,044 |
| Operating expenses: | ||||
| Research & development | 7,341 | 6,313 | 14,054 | 12,372 |
| Selling, general & administrative | 10,949 | 12,230 | 28,721 | 25,136 |
| Total operating expenses | 18,290 | 18,543 | 42,775 | 37,508 |
| Income (loss) from operations | 2,954 | (4,180) | (2,534) | (8,464) |
ITEM 1. FINANCIAL STATEMENTS[ Item 1. Condensed Consolidated Financial Statements (unaudited): ](#)
FAQ
- What is Anika Therapeutics's business segments — gross profit?
- Anika Therapeutics (ANIK) reported business segments — gross profit of $21.24M in Q2 2026.
- What does business segments — gross profit mean?
- Gross profit is the difference between total revenue and the direct costs of producing orthopedic goods and services. It measures the fundamental profitability of the company's core product offerings before accounting for operating expenses.
Ask your AI about Anika Therapeutics's business segments — gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude